Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

PHASE3TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 27, 2014

Primary Completion Date

May 23, 2017

Study Completion Date

May 23, 2017

Conditions
Hepatocellular Carcinoma
Interventions
DEVICE

TheraSphere®

Intrahepatic treatment of advanced hepatocellular carcinoma

DRUG

Sorafenib

Standard of care therapy for treatment of advanced hepatocellular carcinoma

Trial Locations (19)

1200

Cliniques Universitaires Saint-Luc, Brussels

10029

Mount Sinai School of Medicine, New York

12100

ASO-Santa Croce e Carle di Cuneo, Cuneo

13273

Paoli-Calmettes Institute, Marseille

20122

Fondazione IRCCS Ca Grande, Milan

20162

S.C Radiologia Interventistica, A.O.Ospedale Niguarda Ca Granda, Milan

24128

UO Radiologia, Ospedali Riuniti di Bergamo, Bergamo

28041

Bulevar Sur s/n, Madrid

28222

Hospital Universitario Puerta de Hierro, Gastroenterology & Hepatology Dept, Madrid

40138

Azienda Ospedaliero-Universitaria di Bologna, Bologna

46026

Hospital Universitari i Politecnic la Fe, Valencia

56100

University of Pisa, Pisa

60611

Northwestern Medical Faculty Foundation, Div of Hematology/Oncology, Chicago

90147

"Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello", Palermo

I-20133

Fondazione Istituto Nazionale Tumori di Milano, Milan

8 - 00168

Policlinico A. Gemelli, Rome

08036

Hospital Clínic Barcelona. IDIBAPS. CIBEREHD. Liver Unit, Barcelona

B15 2WB

University Hospitals Birmingham NHS Foundation Trust, Birmingham

NW3 2QG

Royal Free London NHS Foundation Trust, London

Sponsors
All Listed Sponsors
collaborator

Biocompatibles UK Ltd

INDUSTRY

lead

Boston Scientific Corporation

INDUSTRY